To this end, this updated meta-analysis evaluated a panel of neurogenic biomarkers, including NSE, S100β, APACHE II, GFAP, TAU, UCH-L1, SOFA, and mortality, to differentiate between sepsis patients with and without encephalopathy. This evidence concerns the gene S100B and Encephalopathy.